The shot log is where a GLP-1 week starts, so it was never going to sit behind an upgrade
Studies have shown that semaglutide can help people lose a significant amount of weight, and even modest weight loss (around 5 to 10 pounds) can positively impact your blood pressure
Reduces lactic acid buildup in muscles, potentially delaying fatigue
GLP-1 Receptor Agonist Market Opportunities: Expanded cardiovascular indications and biosimilar development creating transformative GLP-1 receptor agonist market opportunities The cardiovascular indication expansion following SELECT trial approval for semaglutide in cardiovascular risk reduction in obese non-diabetic patients is qualitatively important because it changes who prescribes GLP-1 drugs
This in turn requires thorough patient education to manage expectations and ensure informed decision-making (Davies, et al., 2021)
Symptoms include fatigue, bone pain, muscle weakness, mood changes like depression, and an increased risk of fractures due to weakened bones